Menu

Shingles

GSK Shingles Vaccine Shingrix Approved for Canada

GlaxoSmithKline’s recombinant zoster vaccine (adjuvanted) (Shingrix) has been approved in Canada for the prevention of herpes zoster (shingles) in people aged 50 years and older. “The vaccine combines an antigen, glycoprotein E, and an adjuvant system, AS01B, intended to generate a strong and long-lasting immune response that can help overcome the decline in immunity as …

GSK Shingles Vaccine Shingrix Approved for Canada Read More »

Zostavax: The Shingles Vaccine & Shingles Protection

Since its approval by Health Canada in 2008, the shingles vaccine (Zostavax®) has been in very high demand even at times becoming unavailable due to manufacturing delays in combination with a demand that may not have been anticipated.  Merck, the company producing Zostavax®, has finally produced enough of the vaccine to fill back orders and …

Zostavax: The Shingles Vaccine & Shingles Protection Read More »

Scroll to Top